Beck Bode LLC’s Thermo Fisher Scientific TMO Stock Holding History

Beck Bode LLC’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,357	Closed	-$8.8M	–	251
2022 Q3	$8.8M	Buy	17,357 +328	+2%	+$184K	1.91%	15
2022 Q2	$9.25M	Buy	17,029 +1,230	+8%	+$677K	1.97%	15
2022 Q1	$9.33M	Buy	15,799 +15,430	+4,182%	+$8.86M	2.1%	15
2021 Q4	$246K	Buy	369 +4	+1%	+$2.5K	0.06%	80
2021 Q3	$209K	Hold	365	–	–	0.06%	84
2021 Q2	$184K	Buy	+365	New	+$172K	0.05%	80
2020 Q4	–	Sell	-336	Closed	-$148K	–	248
2020 Q3	$148K	Buy	+336	New	+$139K	0.05%	65
2020 Q1	–	Sell	-23,781	Closed	-$7.73M	–	74
2019 Q4	$7.73M	Sell	23,781 -363	-2%	-$110K	3.17%	12
2019 Q3	$7.03M	Sell	24,144 -159	-0.7%	-$45.5K	3.09%	12
2019 Q2	$7.14M	Sell	24,303 -56	-0.2%	-$15.4K	3.18%	14
2019 Q1	$6.67M	Sell	24,359 -94	-0.4%	-$23.4K	3.22%	13
2018 Q4	$5.47M	Buy	+24,453	New	+$5.74M	2.98%	14

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's TMO Position: Q4 2022 in Review

Beck Bode LLC sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 17,357 shares — an estimated $8.8M sold.

Beck Bode LLC first reported a position in TMO in Q4 2018 and held it in 12 quarters. The position peaked at $9.33M in Q1 2022. 2,376 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Beck Bode LLC reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
Beck Bode LLC sold 17,357 Thermo Fisher Scientific shares in Q4 2022, an estimated $8.8M.
Beck Bode LLC first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 12 quarters.
Beck Bode LLC's Thermo Fisher Scientific position peaked at $9.33M in Q1 2022.
2,376 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Beck Bode LLC's 13F filing for Q4 2022, filed 8 Feb 2023.